Brainstorm Cell Therapeutics Inc. (BCLI) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 343K | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | -100% | - | - | - | - | - | - |
| Cost of Goods Sold | 37K | 48K | 0 | 0 | 52K | 53K | 59K | 64K | 64K | 66K | 65K | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | 19.24% | - | - |
| Gross Profit | -37K | -48K | 0 | 0 | -52K | -53K | -59K | -64K | -64K | 277K | -65K | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | 80.76% | - | - |
| Gross Profit Growth % | 28.85% | 9.43% | 100% | 100% | 18.75% | -119.13% | 9.23% | - | - | 495.71% | - | - |
| Operating Expenses | 2.01M | 2.2M | 2.05M | 2.57M | 3.09M | 3.19M | 3.05M | 2.98M | 2.47M | 4.74M | 6.04M | 5.45M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | 1381.34% | - | - |
| Selling, General & Admin | 1.28M | -4.39M | 1.15M | 1.45M | 1.78M | 1.47M | 2M | 2.06M | 1.51M | 3.11M | 2.71M | 2.65M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | 905.54% | - | - |
| Research & Development | 725K | -3.32M | 899K | 1.12M | 1.3M | 1.72M | 1.04M | 922K | 897K | 1.7M | 3.33M | 2.79M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | 495.04% | - | - |
| Other Operating Expenses | 0 | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 64K | -66K | 0 | 0 |
| Operating Income | -2.05M | -2.24M | -2.05M | -2.57M | -3.09M | -3.19M | -3.05M | -2.98M | -2.47M | -4.8M | -6.04M | -5.45M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | -1400.58% | - | - |
| Operating Income Growth % | 33.77% | 29.63% | 32.84% | 13.72% | -24.86% | 33.62% | 49.49% | 45.27% | 51.97% | 2.26% | 11.78% | 28.22% |
| EBITDA | -2.01M | -2.2M | -2M | -2.52M | -3.04M | -3.14M | -2.99M | -2.92M | -2.41M | -4.74M | -5.97M | -5.38M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | -1381.34% | - | - |
| EBITDA Growth % | 33.85% | 29.97% | 33.12% | 13.57% | -26.02% | 33.81% | 49.93% | 45.78% | 52.6% | 2.21% | 11.83% | 28.43% |
| D&A (Non-Cash Add-back) | 37K | 48K | 48K | 51K | 52K | 53K | 59K | 64K | 64K | 66K | 65K | 67K |
| EBIT | -2.05M | -2.24M | -2.05M | -2.57M | -3.09M | -3.19M | -3.05M | -2.98M | -2.47M | -5.58M | -6.04M | -5.45M |
| Net Interest Income | -81K | 284K | 0 | -330K | 46K | -66K | -54K | 30K | 13K | -184.12K | -121K | 120K |
| Interest Income | 0 | -46K | 0 | 0 | 46K | 0 | 0 | 30K | 13K | -92.12K | 0 | 120K |
| Interest Expense | 81K | -330K | 0 | 330K | 0 | 66K | 54K | 0 | 0 | 92K | 121K | 0 |
| Other Income/Expense | -81K | -190K | -59K | -330K | 225K | 216K | 340K | 441K | -927K | -774K | 4.81M | 120K |
| Pretax Income | -2.13M | -2.43M | -2.11M | -2.9M | -2.86M | -2.97M | -2.71M | -2.54M | -3.4M | -5.58M | -1.23M | -5.33M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | -1626.24% | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -2.13M | -2.43M | -2.11M | -2.9M | -2.86M | -2.97M | -2.71M | -2.54M | -3.4M | -5.58M | -1.23M | -5.33M |
| Net Margin % | - | - | - | - | - | - | - | - | - | -1626.24% | - | - |
| Net Income Growth % | 25.73% | 18.13% | 22.23% | -14.25% | 15.79% | 46.7% | -120.88% | 52.32% | 32.77% | -11.16% | 82.12% | 24.31% |
| Net Income (Continuing) | -2.13M | -2.43M | -2.11M | -2.9M | -2.86M | -2.97M | -2.71M | -2.54M | -3.4M | -5.58M | -1.23M | -5.33M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.19 | -0.22 | -0.19 | -0.34 | -0.45 | -0.52 | -0.51 | -0.54 | -0.79 | -1.66 | -0.42 | -1.95 |
| EPS Growth % | 57.78% | 57.69% | 62.75% | 37.04% | 43.04% | 68.67% | -21.43% | 72.31% | 62.38% | -1085.71% | 85.26% | 31.58% |
| EPS (Basic) | -0.19 | -0.22 | -0.19 | -0.34 | -0.45 | -0.52 | -0.51 | -0.54 | -0.79 | -1.66 | -0.42 | -1.95 |
| Diluted Shares Outstanding | 11.03M | 9.27M | 11.01M | 8.62M | 6.34M | 5.71M | 5.31M | 4.75M | 4.32M | 3.36M | 2.95M | 2.65M |
| Basic Shares Outstanding | 11.03M | 9.27M | 11.01M | 8.62M | 6.34M | 5.71M | 5.31M | 4.75M | 4.32M | 3.36M | 2.95M | 2.65M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |